Preview

Medical Immunology (Russia)

Advanced search

LONG-TERM CHANGES OF INFLAMMATION MARKERS IN PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROME FOLLOWING CORONARY ARTERY BYPASS GRAFTING SURGERY

https://doi.org/10.15789/1563-0625-2014-2-183-188

Abstract

It was found that soluble intercellular adhesion molecule-1 (ICAM-1) and leukocyte levels in patients with non-ST elevation acute coronary syndrome exhibited a gradual decrease during follow-up period of 6 to 12 months after CABG, as compared with pre-treatment baseline rates. In addition, sICAM-1 level showed an increase at 48 month post-CABG, tending to pre-treatment values. The levels of tumor necrosis factor-alpha (TNFa) and interleukin-6 (IL-6) did not express any significant changes during the entire observation period. TNFα level in the patients with non-STEMI before surgery did not differ from the levels in the patients with stable ischemic heart disease (60.0±9.8 pg/ml and 51.0±6.8 pg/ml; p > 0.05). Serum TNFα level remained unchanged in the patients after CABG. Similar changes were found for IL-6, with no differences between initial levels in the patients with non-STEMI and those with stable coronary artery disease (34.5±3.6 pg/ml and 28.6±3.1 pg/ml; p > 0.05). The IL-6 levels remained virtually unchanged over the observation time. Therefore, the ambiguous results obtained in present study deserve further studies of the role of inflammatory mediators in different clinical forms of ischemic heart disease following CABG.

About the Authors

N. A. Gavricheva
St. Petersburg I. Pavlov State Medical University, St. Petersburg
Russian Federation

PhD, MD (Medicine), Professor, Department of Pathophysiology with a Course of Clinical Pathological Physiology, St. Petersburg I. Pavlov State Medical University



K. V. Korzhenevskaya
Almazov Federal Center of Heart, Blood, and Endocrinology, St. Petersburg
Russian Federation

PhD (Medicine), Senior Research Associate, Almazov Federal Center of Heart Blood, and Endocrinology



G. V. Alekseeva
St. Petersburg I. Pavlov State Medical University, St. Petersburg
Russian Federation

PhD (Medicine), Researche Associate, St. Petersburg I. Pavlov State Medical University



A. V. Panov
Almazov Federal Center of Heart, Blood, and Endocrinology, St. Petersburg
Russian Federation

PhD, MD (Medicine), Professor, Almazov Federal Heart Blood and Endocrinology Center



References

1. Aronov D.M., Lukanov V.P. Nekotorye aspekty patogeneza ateroskleroza [Atherosclerosis and coronary heart disease: some aspects of pathogenesis]. Ateroskleroz i dislipidemii – Atheroslerosis and Dyslipidemia, 2011, no. 1, pp. 46-54.

2. Bokeriya L.A., Bokeriya O.L., Kudzoeva Z.F. Sravnitel`nyy analiz primeneniya koronarnoy angioplastiki i operatsii aorto-koronarnogo shuntirovaniya u patsientov so stabil`noy stenokardiey : istoriya voprosa i sovremennoe sostoyanie problem [Analysis of percu tane ous coronary intervention versus bypass surgery for patients with stable angina: problem background and current status]. Annaly khirurgii – Annals of Surgery, 2009, no. 6, pp. 10-23.

3. Klimov A.N., Shlyakhto E.V. Ateroskleroz. Problemy patogeneza i terapii (Atherosclerosis. Problems of pathogenesis and therapy). Saint-Petersburg: Medical literature, 2006, 248 p.

4. Kostyuchenko G.I., Nikitin Yu.P., Arzamastsev D.D., Anan`ev D.A., Galikhin A.D., Kostyuchenko L.A. Aterotromboz, rol` khronicheskogo sosudistogo vospaleniya [Atherothrombosis, role of сhronic vascular inflammation]. Ateroskleroz – Atherosclerosis, 2011, vol. 7, no. 2, pp. 49-56.

5. Mazurov V.I., Stolov S.V. Linetskaya N.E. Izmenenie produktsii nekotorykh provospalitel`nykh tsitokinov u bol`nykh razlichnymi variantami IBS [Proinflammatory cytokines in patients with ischimic heart disease]. Meditsinskaya immunologiya – Medical Immunology, 1999, vol. 1, no. 5, pp. 53-59.

6. Pavlikova E.P., Meray I.A. Klinicheskoe znachenie interleykina 6 i faktora nekroza opukholi – al`fa pri ishemicheskoy bolezni serdtsa [Clinical significance of inerleukin-6 and tumor necrosis factor-alpha in ischemic heart disease]. Kardiologiya – Cardiology, 2003, vol. 43, no. 8, pp. 68-71.

7. Seledtsov V.I., Litvinova L.S., Seledtsova I.A., Kirienkova E.V., Shupletsova V.V. Gumoral`nye i kletochnye faktory immuniteta pri infarkte miokarda [Humoral and cellular immunity factors in myocardial infarction]. Meditsinskaya immunologiya – Medical Immunology, 2010, vol. 12, no. 6, pp. 477- 484.

8. Freidlin I.S., Totolian A.A. Kletki immunnoy sistemy [Immune system cells]. St. Petersburg, Science, 2001. 390 p.

9. Yaitskiy N.A., Shlyakhto E.V., Petrishchev N.N., Gavrisheva N.A., Hanson G.K. Immunovospalitel` nye aspekty ateroskleroza [Immune mechanisms in atherosclerosis]. Meditsinskiy akademicheskiy zhurnal – Medical Academic Journal, 2007, vol. 7, no. 1, pp. 30-37.

10. Ballantyne C.M., Mark L., Entman M.L. Soluble adhesion molecules and the search for biomarkers for atherosclerosis. Circulation, 2002, vol. 106, no. 7. pp. 766-767.

11. Carlos T.M., Harlan J.M. Leukocyte-endothelial adhesion molecules. Blood, 1994, vol. 84, no. 4, pp. 2068-2101.

12. Libby P., Okamoto Y., Rocha V.Z., Foleo E. Inflammation in atherosclerosis: transition from theory to practice. Circulation, 2010, vol. 74, pp. 213-220.

13. Mueller C., Neumann F.J., Perruchoud A.P., Buettner H.J. White blood cell count and long term mortality after non-ST elevation acute coronary syndrome treated with very early revascularization. Heart, 2003, vol. 89, no. 4, pp. 389-392.

14. Schuett H., Oestreich R., Waetzig G.H., Annema W., Luchtefeld M., Hillmer A., Bavendiek U., von Felden J., Divchev D., Kempf T., Wollert K.C., Seegert D., Rose-John S., Tietge U., Schieffer B., Grote K. Transsignaling of interleukin-6 crucially contributes to atheroscle rosis in mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 2012, vol. 11, pp. 281-290.


Review

For citations:


Gavricheva N.A., Korzhenevskaya K.V., Alekseeva G.V., Panov A.V. LONG-TERM CHANGES OF INFLAMMATION MARKERS IN PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROME FOLLOWING CORONARY ARTERY BYPASS GRAFTING SURGERY. Medical Immunology (Russia). 2014;16(2):183-188. (In Russ.) https://doi.org/10.15789/1563-0625-2014-2-183-188

Views: 826


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1563-0625 (Print)
ISSN 2313-741X (Online)